Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rockwell Medical (RMTI) Depreciation & Amortization (CF) (2016 - 2025)

Historic Depreciation & Amortization (CF) for Rockwell Medical (RMTI) over the last 17 years, with Q3 2025 value amounting to $544000.0.

  • Rockwell Medical's Depreciation & Amortization (CF) rose 18.42% to $544000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $2.2 million, marking a year-over-year increase of 9.14%. This contributed to the annual value of $2.2 million for FY2024, which is 5096.95% up from last year.
  • As of Q3 2025, Rockwell Medical's Depreciation & Amortization (CF) stood at $544000.0, which was up 18.42% from $563000.0 recorded in Q2 2025.
  • In the past 5 years, Rockwell Medical's Depreciation & Amortization (CF) registered a high of $564000.0 during Q3 2023, and its lowest value of $133000.0 during Q4 2021.
  • In the last 5 years, Rockwell Medical's Depreciation & Amortization (CF) had a median value of $202000.0 in 2021 and averaged $342842.1.
  • In the last 5 years, Rockwell Medical's Depreciation & Amortization (CF) tumbled by 3954.55% in 2021 and then soared by 29440.56% in 2023.
  • Over the past 5 years, Rockwell Medical's Depreciation & Amortization (CF) (Quarter) stood at $133000.0 in 2021, then increased by 15.79% to $154000.0 in 2022, then surged by 257.14% to $550000.0 in 2023, then fell by 1.27% to $543000.0 in 2024, then increased by 0.18% to $544000.0 in 2025.
  • Its Depreciation & Amortization (CF) was $544000.0 in Q3 2025, compared to $563000.0 in Q2 2025 and $539000.0 in Q1 2025.